| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |